PDF herunterladen
Zentralbl Chir 2008; 133(2): 123-128
DOI: 10.1055/s-2008-1004733
Übersicht

© Georg Thieme Verlag Stuttgart · New York

Behandlung der Analfissur mit Botulinumtoxin

Treatment of Anal Fissures with Botulinum ToxinU. Wollina1
  • 1Klinik für Dermatologie und Allergologie, Krankenhaus Dresden-Friedrichstadt, Städtisches Klinikum, Akademisches Lehrkrankenhaus der TU Dresden, Dresden
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
15. April 2008 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Die chronische Analfissur ist ein häufiges proktologisches Leiden. Für die chemische temporäre Denervierung kann Botulinumtoxin (BTX) eingesetzt werden. Die Applikation erfolgt mittels intramuskulärer Injektion in den äußeren oder inneren Sphincter ani. Wirkungsweise, Applikationstechnik, mögliche Komplikationen und Nebenwirkungen werden besprochen. Die Heilungsraten sind dosisabhängig und liegen kurzfristig (≤ 6 Monate) zwischen 60 und 90 %. Die Heilungsraten bei Nachbeobachtung > 1 Jahr erreichen ca. 50 %. Die Nebenwirkungen sind gering, Rezidive aber häufiger als bei chirurgischer Behandlung. Dennoch wird heute die Anwendung der konservativen Verfahren einschließlich BTX überwiegend in der First-Line-Therapie der chronischen Analfissur verwendet. Unter den chirurgischen Verfahren bleibt die laterale Sphinkterotomie der Goldstandard, der allerdings mit einer höheren Inkontinenz- und allgemeinen Morbiditätsrate einhergeht als dies für BTX der Fall ist.

Abstract

Chronic anal fissure is a common proctological disease. Botulinum toxin (BTX) can be used for temporary chemical denervation. The administration is by intramuscular injections into either the external or the internal anal sphincter muscles. The mode of action, administration techniques and possible complications or adverse effects of BTX therapy are discussed. The healing rate is dependent on the BTX dosage. The short-term healing rate (≤ 6 months) is between 60 and 90 %. In long-term follow-up studies (> 1 year), about 50 % of patients show a complete response. Adverse effects are generally mild but relapses occur more often compared to surgery. Conservative therapies including BTX are currently considered mostly as the first-line treatment. Among the surgical procedures, lateral sphincterotomy is the most effective treatment but shows higher incontinence and general morbidity rates than BTX.

Schlüsselwörter

Analfissur - Botulinumtoxin - laterale Sphinkterotomie - Therapiealgorithmus

Key words

anal fissure - botulinum toxin - lateral sphincterotomy - therapeutic algorithm

Literatur

  • 1 Acheson A G, Scholefield J H. Pharmacological advancements in the treatment of chronic anal fissure.  Expert Opin Pharmacother. 2005;  6 2475-2481
    CrossrefPubMedGoogle Scholar
  • 2 Arroyo A, Pérez F, Serrano P, Candela F, Calpena R. Long-term results of botulinum toxin for the treatment of chronic anal fissure: prospective clinical and manometric study.  Int J Colorectal Dis. 2005;  20 267-271
    CrossrefPubMedGoogle Scholar
  • 3 Arroyo A, Pérez F, Serrano P, Candela F, Lacueva J, Calpena R. Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study.  Am J Surg. 2005;  189 429-434
    CrossrefPubMedGoogle Scholar
  • 4 Bechara F G, Sand M, Sand D, Achenbach R K, Altmeyer P, Hoffmann K. Focal hyperhidrosis of the anal fold: a simple technique for diagnosis and evaluation of therapy.  Br J Dermatol. 2006;  155 858
    PubMedGoogle Scholar
  • 5 Bhardwaj R, Vaizey C J, Boulos P B, Hoyle C H. Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures.  Gut. 2000;  46 861-868
    CrossrefPubMedGoogle Scholar
  • 6 Brin M E. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.  Muscle Nerve. 1997;  20 (Suppl 6) S 146-S 168
    PubMedGoogle Scholar
  • 7 Brisinda G, Maria G, Bentivoglio A R, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerine ointment for the treatment of chronic anal fissure.  N Engl J Med. 1999;  341 65-69
    CrossrefPubMedGoogle Scholar
  • 8 Brisinda G, Maria G, Sganga G, Bentivoglio A R, Albanese A, Castagneto M. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures.  Surgery. 2002;  131 179-184
    CrossrefPubMedGoogle Scholar
  • 9 Colak T, Ipek T, Kanik A, Aydin S. A randomized trial of botulinum toxin vs. lidocain pomade for chronic anal fissure.  Acta Gastro-Enterol Belg. 2002;  65 187-190
    PubMedGoogle Scholar
  • 10 De Nardi P, Ortolano E, Radaelli G, Stadacher C. Comparison of glycerine trinitrate and botulinum toxin-A for the treatment of chronic anal fissures: long-term results.  Dis Colon Rectum. 2006;  49 427-432
    CrossrefPubMedGoogle Scholar
  • 11 Essani R, Sarkisyan G, Beart R W, Ault G, Vukasin P, Kaiser A M. Cost-saving effect of treatment algorithm for chronic anal fissure: a prospective analysis.  J Gastrointest Surg. 2005;  9 1237-1244
    CrossrefPubMedGoogle Scholar
  • 12 Fernandez-Lopez F, Conde Freire R, Rios Rios A, Carcia Iglesias J, Cainzos Fernandez M, Potel Lesquereux J. Botulinum toxin for the treatment of anal fissure.  Dig Surg. 1999;  16 515-518
    CrossrefPubMedGoogle Scholar
  • 13 Floyd N D, Kondylis L, Kondylis P D, Reilly J C. Chronic anal fissure: 1994 and a decade later - are we doing better?.  Am J Surg. 2006;  191 344-348
    CrossrefPubMedGoogle Scholar
  • 14 Giral A, Memisoglu K, Gültekin Y, Imeryüz N, Kalayc C, Ulusoy N B, Tözün N. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial.  BMC Gastroenterol. 2004;  4 7
    CrossrefPubMedGoogle Scholar
  • 15 Godevenos D, Pikoulis E, Pavlakis E, Daskalakis P, Stathoulopoulos A, Gavrielatou E, Leppäniemi A. The treatment of chronic anal fissure with botulinum toxin.  Acta Chir Belg. 2004;  104 577-580
    PubMedGoogle Scholar
  • 16 Gui D, Cassetta E, Anastasio G, Bentivoglo A R, Maria G, Albanese A. Botulinum toxin for chronic anal fissure.  Lancet. 1994;  344 1127-1128
    CrossrefPubMedGoogle Scholar
  • 17 Horsch D, Kirsch J J, Weihe E. Elevated density and plasticity of nerve fibres in anal fissures.  Int J Colorectal Dis. 1998;  13 134-140
    CrossrefPubMedGoogle Scholar
  • 18 Huang W, Foster J A, Rogachefsky A S. Pharmacology of botulinum toxin.  J Am Acad Dermatol. 2000;  43 249-259
    CrossrefPubMedGoogle Scholar
  • 19 Iswariah H, Stephens J, Rieger N, Rodda D, Hewett P. Randomized prospective controlled trial of lateral internal sphincterotomy versus injections of botulinum toxin for the treatment of idiopathic fissure in ano.  ANZ J Surg. 2005;  75 553-555
    CrossrefPubMedGoogle Scholar
  • 20 Jones O M, Brading A F, McC Mortensen N J. The physiology, pharmacology and therapeutic manipulation of the internal anal sphincter.  Can J Gastroenterol. 2002;  16 249-257
    PubMedGoogle Scholar
  • 21 Jost W H. One hundred cases of anal fissure treated with botulinum toxin: early and long-term results.  Dis Colon Rectum. 1997;  40 1029-1032
    CrossrefPubMedGoogle Scholar
  • 22 Jost W H, Schannes S, Mlitz H, Schimrigk K. Perianal thrombosis following injection therapy into the external sphincter using botulinum toxin.  Dis Colon Rectum. 1995;  38 781
    CrossrefPubMedGoogle Scholar
  • 23 Jost W H, Schimrigk K. Use of botulinum toxin in anal fissure.  Dis Colon Rectum. 1993;  36 974
    CrossrefPubMedGoogle Scholar
  • 24 Jost W H, Schimrigk K. Therapy of anal fissure using botulinum toxin.  Dis Colon Rectum. 1994;  37 1340
    PubMedGoogle Scholar
  • 25 Kinney T P, Shah A G, Rogers B HG, Ehrenpreis E D. Retrograde endoscopic delivery of botulinum toxin for anal fissures.  Endoscopy. 2006;  38 654
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 26 Lindsey I, Jones O M, Cinningham C, George B D, Mostensen N JM. Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate.  Dis Colon Rectum. 2003;  46 361-366
    CrossrefPubMedGoogle Scholar
  • 27 Lysy J, Israelit-Ytzkan Y, Sestiery-Ittah M, Weksler-Zangen S, Keret D, Goldin E. Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure.  Gut. 2001;  48 221-224
    CrossrefPubMedGoogle Scholar
  • 28 Madalinski M H, Slawek J, Zbytek B, Duzynski W, Adrich Z, Jagiello K, Kryszewski A. Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure.  Hepato-Gastroenterol. 2001;  48 977-979
    PubMedGoogle Scholar
  • 29 Maria G, Casetta E, Gui D, Brisinda G, Bentivoglio A R, Albanese A. A comparison of botulin toxin and salin for the treatment of chronic anal fissure.  N Engl J Med. 1998;  338 217-220
    CrossrefPubMedGoogle Scholar
  • 30 Maria G, Brisinda G, Bentivoglio A R, Cassetta E, Gui D, Albanese A. Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: long-term results after two different dosage regimens.  Ann Surg. 1998;  228 664-669
    CrossrefPubMedGoogle Scholar
  • 31 Maria G, Brisidina G, Bentivoglio A R, Cassetta E, Gui D, Albanese A. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure.  Am J Surg. 2000;  179 46-50
    CrossrefPubMedGoogle Scholar
  • 32 Massoud B -W, Mehrdad V, Baharak T, Alireza Z. A comparison of botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure.  Ann Saudi Med. 2005;  25 140-142
    PubMedGoogle Scholar
  • 33 McCallion K, Gardiner K R. Progress in the understanding and treatment of chronic anal fissure.  Postgrad Med J. 2001;  77 753-758
    CrossrefPubMedGoogle Scholar
  • 34 Mentes B B, Írkörücü, Akin M, Leventoglu S, Tatlicioglu E. Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.  Dis Colon Rectum. 2003;  46 232-237
    CrossrefPubMedGoogle Scholar
  • 35 Minguez M, Melo F, Espi A, Garcia-Granero E, Mora F, Lledo S, Benages A. Therapeutic effects of different doses of botulinum toxin in chronic anal fissure.  Dis Colon Rectum. 1999;  42 1016-1021
    PubMedGoogle Scholar
  • 36 Nelson R. Operative procedures for fissure in ano (Cochrane Review).  Cochrane Database Syst Rev. 2001;  3 CD002199
    PubMedGoogle Scholar
  • 37 Nelson R. A systematic review of medical therapy for anal fissure.  Dis Colon Rectum. 2004;  47 422-431
    CrossrefPubMedGoogle Scholar
  • 38 Orsay C, Rakinic J, Perry W B, Hyman N, Buie D, Cataldo P, Newstead G, Dunn G, Rafferty J, Ellis N, Shellito P, Gregorcyk S, Ternent C, Kilkenny III J, Tjandra J, Ko C, Whiteford M, Nelson R. Practise parameters for the management of anal fissures (revised) prepared by The Standard Practise Task Force, The American Society of Colon and Rectal Surgeons.  Dis Colon Rectum. 2004;  47 2003-2007
    CrossrefPubMedGoogle Scholar
  • 39 Rosales R L, Bigalke H, Dressler D. Pharmacology of botulinum toxin: differences between type A preparations.  Eur J Neurol. 2006;  13 (Suppl 1) 2-10
    PubMedGoogle Scholar
  • 40 Singer M, Citron J. New techniques in the treatment of common perianal diseases: stapled hemorrhoidopexy, botulinum toxin, and fibrin sealant.  Surg Clin North Am. 2006;  86 937-967
    CrossrefPubMedGoogle Scholar
  • 41 Siproudhis L, Sebille V, Pigot F, Hemery P, Juguet F, Bellisant E. Lack of efficacy of botulinum toxin in chronic anal fissure.  Aliment Pharmacol Ther. 2003;  18 515-524
    CrossrefPubMedGoogle Scholar
  • 42 Tranqui P, Trottier D C, Victor J C, Freeman J B. Nonsurgical treatment of chronic anal fissure: nitroglycerin and dilatation versus nifedipine and botulinum toxin.  Can J Surg. 2006;  49 41-45
    PubMedGoogle Scholar
  • 43 Trcinski R, Dziki A, Tchórzewski A. Injections of botulinum A toxin for the treatment of anal fissures.  Eur J Surg. 2002;  168 720-723
    CrossrefPubMedGoogle Scholar
  • 44 Utzig M J, Kroesen A J, Buhr H J. Concepts in pathogenesis and treatment of chronic anal fissure - a review of the literature.  Am J Gastroenterol. 2003;  98 968-974
    PubMedGoogle Scholar
  • 45 Wollina U, Abdel-Naser M B. Pharmacotherapy of pompholyx.  Expert Opin Pharmacother. 2004;  5 1517-1522
    CrossrefPubMedGoogle Scholar
  • 46 Wollina U, Konrad H. Botulinum toxin A in anal fissures: a modified technique.  J Eur Acad Dermatol Venereol. 2002;  16 469-471
    CrossrefPubMedGoogle Scholar
  • 47 Wollina U, Konrad H. Managing adverse effects associated with botulinum toxin type A.  Am J Clin Dermatol. 2005;  6 141-150
    CrossrefPubMedGoogle Scholar
  • 48 Wollina U, Konrad H, Petersen S. Botulinum toxin in dermatology - beyond wrinkles and sweat.  J Cosmet Dermatol. 2005;  4 223-227
    CrossrefPubMedGoogle Scholar

Prof. Dr. U. Wollina

Klinik für Dermatologie und Allergologie · Krankenhaus Dresden-Friedrichstadt · Städtisches Klinikum · Akademisches Lehrkrankenhaus der TU Dresden

Friedrichstraße 41

01067 Dresden

Telefon: 03 51 / 4 80 16 85

Fax: 03 51 / 4 80 12 19

eMail: wollina-uw@khdf.de